Nicholas Company, Inc. Thermo Fisher Scientific Inc. Transaction History

Nicholas Company, Inc.

  • $5.89 Billion
  • Q2 2024

A detailed history of Nicholas Company, Inc. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Nicholas Company, Inc. holds 134,958 shares of TMO stock, worth $80.8 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares
134,958
Previous 134,958 -0.0%
Holding current value
$80.8 Million
Previous $78.4 Million 4.85%
% of portfolio
1.27%
Previous 1.32%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$528.82 - $599.43 $5,288 - $5,994
10 Added 0.01%
134,958 $78.4 Million
Q3 2023

Feb 13, 2024
SELL
$498.29 - $574.41 $122,081 - $140,730
-245 Reduced 0.18%
134,948 $68.3 Million
Q3 2023

Nov 13, 2023
SELL
$498.29 - $574.41 $122,081 - $140,730
-245 Reduced 0.18%
134,948 $68.3 Million
Q4 2022

Feb 13, 2024
SELL
$484.71 - $571.37 $9,694 - $11,427
-20 Reduced 0.01%
135,193 $74.5 Million
Q4 2022

Feb 09, 2023
SELL
$484.71 - $571.37 $9,694 - $11,427
-20 Reduced 0.01%
135,193 $74.5 Million
Q2 2022

Feb 13, 2024
SELL
$500.9 - $612.21 $25,545 - $31,222
-51 Reduced 0.04%
135,213 $73.5 Million
Q2 2022

Jul 26, 2022
SELL
$500.9 - $612.21 $25,545 - $31,222
-51 Reduced 0.04%
135,213 $73.5 Million
Q1 2022

Feb 13, 2024
BUY
$524.0 - $644.92 $165,584 - $203,794
316 Added 0.23%
135,264 $79.9 Million
Q1 2022

May 11, 2022
SELL
$524.0 - $644.92 $3.16 Million - $3.89 Million
-6,025 Reduced 4.26%
135,264 $79.9 Million
Q4 2021

Feb 11, 2022
SELL
$569.0 - $667.24 $19.8 Million - $23.2 Million
-34,760 Reduced 19.74%
141,289 $94.3 Million
Q3 2021

Nov 15, 2021
SELL
$509.53 - $609.78 $15,285 - $18,293
-30 Reduced 0.02%
176,049 $101 Million
Q2 2021

Aug 12, 2021
SELL
$441.0 - $508.24 $1.5 Million - $1.73 Million
-3,395 Reduced 1.89%
176,079 $88.8 Million
Q1 2021

May 14, 2021
SELL
$439.85 - $518.83 $197,932 - $233,473
-450 Reduced 0.25%
179,474 $81.9 Million
Q4 2020

Feb 10, 2021
SELL
$435.06 - $527.66 $24.1 Million - $29.3 Million
-55,465 Reduced 23.56%
179,924 $83.8 Million
Q3 2020

Nov 13, 2020
SELL
$359.77 - $441.52 $1.82 Million - $2.23 Million
-5,045 Reduced 2.1%
235,389 $104 Million
Q2 2020

Aug 13, 2020
BUY
$275.2 - $362.34 $2,752 - $3,623
10 Added 0.0%
240,434 $87.1 Million
Q1 2020

May 13, 2020
SELL
$255.3 - $340.05 $7.73 Million - $10.3 Million
-30,260 Reduced 11.18%
240,424 $68.2 Million
Q4 2019

Feb 13, 2020
SELL
$271.93 - $328.04 $85,657 - $103,332
-315 Reduced 0.12%
270,684 $87.9 Million
Q3 2019

Nov 14, 2019
SELL
$268.46 - $305.43 $21.6 Million - $24.6 Million
-80,415 Reduced 22.88%
270,999 $78.9 Million
Q2 2019

Aug 13, 2019
SELL
$257.51 - $295.55 $5.19 Million - $5.96 Million
-20,155 Reduced 5.42%
351,414 $103 Million
Q1 2019

May 14, 2019
SELL
$212.17 - $273.72 $2.57 Million - $3.31 Million
-12,090 Reduced 3.15%
371,569 $102 Million
Q4 2018

Feb 14, 2019
SELL
$208.47 - $251.98 $41,694 - $50,396
-200 Reduced 0.05%
383,659 $85.9 Million
Q3 2018

Nov 14, 2018
SELL
$205.57 - $244.32 $12.2 Million - $14.5 Million
-59,195 Reduced 13.36%
383,859 $93.7 Million
Q2 2018

Aug 14, 2018
SELL
$203.14 - $219.53 $21.1 Million - $22.8 Million
-103,705 Reduced 18.97%
443,054 $91.8 Million
Q1 2018

May 14, 2018
SELL
$192.98 - $224.11 $5.55 Million - $6.45 Million
-28,780 Reduced 5.0%
546,759 $113 Million
Q4 2017

Feb 14, 2018
SELL
$182.03 - $200.37 $728,120 - $801,480
-4,000 Reduced 0.69%
575,539 $109 Million
Q3 2017

Nov 14, 2017
SELL
$171.74 - $194.04 $2.65 Million - $2.99 Million
-15,405 Reduced 2.59%
579,539 $110 Million
Q2 2017

Aug 11, 2017
BUY
N/A
594,944
594,944 $104 Million

Others Institutions Holding TMO

# of Institutions
2,779
Shares Held
340M
Call Options Held
1.42M
Put Options Held
2.15M
View Full List

About THERMO FISHER SCIENTIFIC INC.

TMO Quotes by TradingView
  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $235B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Nicholas Company, Inc. Portfolio

Follow Nicholas Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Company, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email